HOLISTA COLLTECH LIMITED — Director's Dealing 2020

Apr 8, 2020

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	HOLISTA COLLTECH LIMITED
ABN	094 515 992

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Rajendran Marnickavasagar
Date of last notice	8 February 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Part 1 - Change of director’s relevant inteIn the case of a trust, this includes interests in the trNote: In the case of a company, interests which come withidisclosed in this part.Direct or indirect interest	Part 1 - Change of director’s relevant inteIn the case of a trust, this includes interests in the trNote: In the case of a company, interests which come withidisclosed in this part.Direct or indirect interest	rests in securitust made available bn paragraph (i) of the d	rests in securitust made available bn paragraph (i) of the d	ies	ies
				y the responsible eefinition of “notifiable	ntity of theinterest of	trusta director” should be
	Direct or indirect interest		Direct
	Nature of indirect interest		-
	(including registered holder)Note: Provide details of the circumstances giving rise t	o the
	relevant interest.
	Date of change		3 April 20	20
	No. of securities held prior to change		Direct
			20,921,0	27 Ordinary Full	y Paid Sh	ares
			3,600,02,700,0	0 Class A Perfo00 Class B Perfo	rmancermance R	ightsights
			1,800,0	00 Class C Perfo	rmance R	ights
			900,0	0 Class D Perfo	rmance	ights
			Indirect
			58,514,2Held byG	45alen Biomedica	l Inc.(dir	ector controlled	entity)
	Class		Ordinary	Fully Paid Share	s
	Number acquired		6,300,00
	Number disposed		-
	Value/ConsiderationNote: If consideration is non-cash, provide details	and	Nil
	estimated valuation

• See chapter 19 for defined terms. 01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	Direct27,221,027 Ordinary Fully Paid Shares1,800,000 Class C Performance Rights900,000 Class D Performance RightsIndirect58,514,245Held by Galen Biomedical Inc. (director controlled entity)
Nature of changeExample: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestment plan,participation in buy-back	Conversion of 3,600,000 Class A Performance Rights and2,700,000 Class B Performance Rights(Refer to ASX Announcement dated 8 April 2020 titled‘Achievement of Performance Rights Milestones’)

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	-
Nature of interest	-
Name of registered holder(if issued securities)	-
Date of change	-
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed	-
Interest acquired	-
Interest disposed	-
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	-
Interest after change	-

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed abovetraded during a+closed period where prior written clearancewas required?	N/A
If so, was prior written clearance provided to allow the trade toproceed during this period?	N/A
If prior written clearance was provided, on what date was thisprovided?	N/A

• See chapter 19 for defined terms. 01/01/2011

Appendix 3Y Page 2